Back to Archived Journals » Oncolytic Virotherapy » Volume 4

Myxoma virus attenuates expression of activating transcription factor 4 (ATF4) which has implications for the treatment of proteasome inhibitor–resistant multiple myeloma

Total article views   HTML views PDF downloads Totals
8,696 Dovepress* 8,348+ 1,294 9,642
PubMed Central* 348 102 450
Totals 8,696 1,396 10,092
*Since 13 January 2015
+Since July 2016

View citations on PubMed Central and Google Scholar